Researchers say new research findings might point to a major opportunity to act sooner to prevent rheumatoid arthritis.

The most important takeaway from the study is that these data suggest that CD47 is an attractive target for drug development.

Julianna LeMieux and Uduak Thomas discuss their time at the ASHG meeting in Denver and some of the trends that they are ...